hypertension Clinical Trials and Research
Also known as: high blood pressure, hbp, elevated blood pressure, htn, systemic hypertension, essential hypertension · ICD-10: I10
Hypertension, or high blood pressure, is a common condition where blood pressure is consistently too high, increasing health risks. Clinical trial research aims to find new ways to prevent, diagnose, and treat hypertension, including novel medications and lifestyle interventions. Find a Trial helps patients search for active studies.
Common questions about hypertension clinical trials
Who can participate in hypertension clinical trials?
Eligibility criteria vary by study, often including age, blood pressure levels, and overall health status. Researchers ensure participant safety and study relevance by carefully defining who can join, as seen on ClinicalTrials.gov.
What are the different phases of hypertension clinical trials?
Clinical trials progress through phases (1, 2, 3, 4) to test safety and effectiveness. Early phases involve fewer participants, while later phases test new treatments in larger groups, as detailed on ClinicalTrials.gov.
Do participants pay to join hypertension clinical trials?
Generally, participants do not pay to join clinical trials, and study-related medical care is often provided at no cost. However, non-study medical expenses and travel costs may not be covered, as outlined in study protocols.
What are current research directions for hypertension treatments?
Current research explores new drug targets, device-based therapies, and personalized medicine approaches for hypertension. Scientists are also investigating genetic factors and lifestyle interventions to improve blood pressure control, according to NIH RePORTER and ClinicalTrials.gov.
What types of interventions are tested in hypertension clinical trials?
Trials evaluate various interventions, including new medications, different dosing regimens, and combination therapies. Lifestyle modifications like diet and exercise programs, and even medical devices, are also frequently studied for their impact on blood pressure, as shown on ClinicalTrials.gov.
Are there specific biomarkers used in hypertension research?
Researchers often use blood pressure readings as a primary biomarker. Other biomarkers under investigation include genetic markers, inflammatory markers, and indicators of kidney or cardiovascular function, which can help predict treatment response or disease progression, according to NIH RePORTER.
What might prevent someone from joining a hypertension trial?
Common exclusion criteria can include uncontrolled co-existing medical conditions, specific medication use, or a history of certain cardiovascular events. These criteria help ensure participant safety and the study's scientific integrity, as detailed on ClinicalTrials.gov.
How do hypertension clinical trials measure success?
Success is often measured by changes in blood pressure readings, such as systolic and diastolic pressure. Other outcomes include reductions in cardiovascular events, improvements in quality of life, or changes in specific biomarkers, as reported on ClinicalTrials.gov.
How to find a hypertension trial that fits you
- Describe your hypertension situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all hypertension trials →